Alnylam Pharmaceuticals
Develops RNAi therapeutics to treat rare and common diseases.
BiotechnologyPharmaceuticals
Company facts
- Founded
- 2002
- Employees
- 2,500
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: ALNY
Develops RNAi therapeutics to treat rare and common diseases.
Company facts